```json
{
"content": [
{
"type": "paragraph",
"content": "The Intermittent Pneumatic Antithrombotic Pump (IPAP) market focuses on devices designed to prevent deep vein thrombosis and pulmonary embolism through cyclic compression of leg segments, promoting blood flow. As a critical tool in post-operative and immobilized patient care, the IPAP market is central to advancing thrombosis prevention strategies. The global Intermittent Pneumatic Antithrombotic Pump market size is projected to surpass $380 million by 2026, with a CAGR of 6.2% from 2026 to 2033, driven by rising hospital-acquired infection prevention mandates and growing geriatric populations. Key macro drivers include the expansion of ambulatory surgical centers and advancements in portable, IoT-enabled IPAP devices."
},
{
"type": "chart",
"chartType": "segment-stacked",
"data": {
"segments": ["Hospitals", "Clinics", "Home Care"],
"periods": ["2021", "2022", "2023", "2024", "2025", "2026", "2027", "2028", "2029", "2030", "2031", "2032", "2033"],
"values": [
[200, 215, 230, 245, 260, 275, 290, 305, 320, 335, 350, 365, 380], // Hospitals
[80, 85, 90, 95, 100, 105, 110, 115, 120, 125, 130, 135, 140], // Clinics
[50, 55, 60, 65, 70, 75, 80, 85, 90, 95, 100, 105, 110] // Home Care
]
}
},
{
"type": "paragraph",
"content": "The market is reshaped by technological innovation in compact, battery-operated IPAP systems and stricter regulatory frameworks like the FDA’s 2024 update on venous thromboembolism (VTE) prevention protocols. North America remains the largest regional market due to high geriatric care expenditure, while Asia-Pacific leads in growth, fueled by rising disposable incomes and healthcare infrastructure investments in India and China. Strategic partnerships between device manufacturers and telehealth platforms are unlocking new market expansion opportunities, positioning the IPAP industry as a cornerstone in preventive cardiovascular care."
}
]
}
```
